Ridho Islamie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ridho Islamie has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ratchanee Rodsiri
Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
2 shared publications Aguslina Kirtishanti
Department of Clinical and Community Pharmacy, Faculty of Pharmacy, University of Surabaya, Surabaya 60293, Indonesia
1 shared publicationAusana Wongtayan
1 shared publicationBayu Cakra Buana
1 shared publication- Boonsong Wungsintaweekul
School of Pharmacy, Walailak University, Nakhon Si Thammarat, Thailand
1 shared publication - Finna Setiawan
Department of Drug Discovery and Development, Faculty of Pharmacy, University of Surabaya, East Java, Indonesia
1 shared publication
Latest Publications
- Open Access
- 11 August 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (9) , 776-794
Medicinal Plants for Hemorrhoid Therapy: Mechanistic Insights, Bioactive Compounds, and Preclinical-to-Clinical Evidence
Hemorrhoid is a multifactorial condition involving inflammation, venous stasis, degeneration of supporting tissue, and vascular fragility. It requires safer adjunctive therapy options for long-term use. This narrative review seeks to comprehensively examine potential anti-hemorrhoidal medicinal plants by linking bioactive compounds, pharmacological targets, and evidence from in vitro , in vivo , and clinical trials. Literature searches were conducted using PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar, focusing on original research articles that documented anti-inflammatory, antioxidant, venoprotective-venotonic, hemostatic-astringent, analgesic, and wound healing activities. The articles were further synthesized qualitatively according to the pathophysiology of hemorrhoids. A total of 90 articles met the inclusion criteria and were classified based on the predominant mechanism, namely anti-inflammatory–antioxidant agents (14 plants; 41 articles), vasoprotective–venotonic agents (6 plants; 10 articles), astringent–hemostatic agents (6 plants; 14 articles), and analgesic and wound healing acceleration (7 plants; 25 articles). The findings showed that medicinal plants operate through a multitarget manner by suppressing inflammatory mediators, increasing endogenous antioxidant defenses, improving venous tone and microvascular stability, supporting local hemostasis, and accelerating mucosal regeneration. Nonetheless, the evidence remains predominantly derived from preclinical studies, with variations in extraction methods, formulations, routes of administration, and dosages. Overall, medicinal plants have potential as adjuvant therapy for hemorrhoids; nevertheless, standardization of extracts and controlled clinical trials are necessary to ensure efficacy and safety.
- 11 August 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (9) , 776-794
Open AccessMedicinal Plants for Hemorrhoid Therapy: Mechanistic Insights, Bioactive Compounds, and Preclinical-to-Clinical Evidence
Hemorrhoid is a multifactorial condition involving inflammation, venous stasis, degeneration of supporting tissue, and vascular fragility. It requires safer adjunctive therapy options for long-term use. This narrative review seeks to comprehensively examine potential anti-hemorrhoidal medicinal plants by linking bioactive compounds, pharmacological targets, and evidence from in vitro , in vivo , and clinical trials. Literature searches were conducted using PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar, focusing on original research articles that documented anti-inflammatory, antioxidant, venoprotective-venotonic, hemostatic-astringent, analgesic, and wound healing activities. The articles were further synthesized qualitatively according to the pathophysiology of hemorrhoids. A total of 90 articles met the inclusion criteria and were classified based on the predominant mechanism, namely anti-inflammatory–antioxidant agents (14 plants; 41 articles), vasoprotective–venotonic agents (6 plants; 10 articles), astringent–hemostatic agents (6 plants; 14 articles), and analgesic and wound healing acceleration (7 plants; 25 articles). The findings showed that medicinal plants operate through a multitarget manner by suppressing inflammatory mediators, increasing endogenous antioxidant defenses, improving venous tone and microvascular stability, supporting local hemostasis, and accelerating mucosal regeneration. Nonetheless, the evidence remains predominantly derived from preclinical studies, with variations in extraction methods, formulations, routes of administration, and dosages. Overall, medicinal plants have potential as adjuvant therapy for hemorrhoids; nevertheless, standardization of extracts and controlled clinical trials are necessary to ensure efficacy and safety.
- Open Access
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Dicaffeoylquinic Acid–Rich Sunflower Sprout Extract Attenuates High‐Fat Diet‐Induced Obesity in Rats
Obesity is a major hallmark of metabolic syndrome and is strongly associated with an increased risk of cardiovascular disease progression. Sunflower sprouts are a particularly rich source of caffeoylquinic acids (CQAs), compounds recognized for their capacity to attenuate weight gain and mitigate dyslipidemia. Sunflower sprout extract (SSE) used in this study was enriched in dicaffeoylquinic acids (diCQAs) and chlorogenic acid (5‐CQA). To evaluate its effects, male Wistar rats were first induced to develop obesity by receiving a high‐fat diet for four months, after which they were given daily oral administration of SSE for an additional 12 weeks. The effects of SSE against HFD‐induced obesity were evaluated by examining liver pathology, antioxidant activity, and biochemistry, including lipid profiles and liver and renal functions. Body weight, food intake, biochemistry, and complete blood count (CBC) were monitored for 12 weeks. SSE treatment significantly decreased body weight gain (at 4 and 8 weeks), food intake (at 8 weeks), triglyceride levels (at 4 weeks), and low‐density lipoprotein (LDL) levels (at 12 weeks) in HFD rats. Total cholesterol, ALT, ALP, BUN, and uric acid levels in HFD‐control and HFD‐SSE rats were not significantly affected, while creatinine levels only increased after 8 weeks of SSE treatment in HFD rats. Importantly, SSE treatment significantly increased catalase and NQO1 expression in HFD‐fed rat liver. Collectively, these results suggested that diCQA‐rich SSE may offer beneficial effects for the management of obesity and associated metabolic disorders.
- 1 January 2026
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2026 (1)
Open AccessDicaffeoylquinic Acid–Rich Sunflower Sprout Extract Attenuates High‐Fat Diet‐Induced Obesity in Rats
Obesity is a major hallmark of metabolic syndrome and is strongly associated with an increased risk of cardiovascular disease progression. Sunflower sprouts are a particularly rich source of caffeoylquinic acids (CQAs), compounds recognized for their capacity to attenuate weight gain and mitigate dyslipidemia. Sunflower sprout extract (SSE) used in this study was enriched in dicaffeoylquinic acids (diCQAs) and chlorogenic acid (5‐CQA). To evaluate its effects, male Wistar rats were first induced to develop obesity by receiving a high‐fat diet for four months, after which they were given daily oral administration of SSE for an additional 12 weeks. The effects of SSE against HFD‐induced obesity were evaluated by examining liver pathology, antioxidant activity, and biochemistry, including lipid profiles and liver and renal functions. Body weight, food intake, biochemistry, and complete blood count (CBC) were monitored for 12 weeks. SSE treatment significantly decreased body weight gain (at 4 and 8 weeks), food intake (at 8 weeks), triglyceride levels (at 4 weeks), and low‐density lipoprotein (LDL) levels (at 12 weeks) in HFD rats. Total cholesterol, ALT, ALP, BUN, and uric acid levels in HFD‐control and HFD‐SSE rats were not significantly affected, while creatinine levels only increased after 8 weeks of SSE treatment in HFD rats. Importantly, SSE treatment significantly increased catalase and NQO1 expression in HFD‐fed rat liver. Collectively, these results suggested that diCQA‐rich SSE may offer beneficial effects for the management of obesity and associated metabolic disorders.
- Open Access
- 1 January 2024
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2024 (1) , 9941034
Nasal Delivery of Asiatic Acid Ameliorates Scopolamine‐Induced Memory Dysfunction in Mice
Asiatic acid (AA) has previously shown its neuroprotective effects, but low oral bioavailability limits its penetration into the brain. This study aimed to investigate the effect of intranasal AA administration in mice with memory dysfunction induced by scopolamine. Mice received either intranasal AA (INAA), oral AA (POAA3 or POAA30), or donepezil, followed by scopolamine for 10 days. Morris water maze (MWM) was performed on days 0–5, 30 min after treatment. Locomotor activity was conducted on day 6 followed by brain collection. In MWM, INAA treatment had significantly reduced escape latency on days 2–4, while POAA3 decreased escape latency on day 3 and POAA30 and donepezil decreased escape latency on day 4. INAA inhibited acetylcholinesterase activity, increased catalase protein expression, and decreased malondialdehyde levels in the brain tissue. Therefore, intranasal administration of AA produced a rapid onset in the protection of learning and memory deficits induced by scopolamine through acetylcholinesterase inhibition and antioxidant effect.
- 1 January 2024
- Published by Wiley in Advances in Pharmacological and Pharmaceutical Sciences
- Vol. 2024 (1) , 9941034
Open AccessNasal Delivery of Asiatic Acid Ameliorates Scopolamine‐Induced Memory Dysfunction in Mice
Asiatic acid (AA) has previously shown its neuroprotective effects, but low oral bioavailability limits its penetration into the brain. This study aimed to investigate the effect of intranasal AA administration in mice with memory dysfunction induced by scopolamine. Mice received either intranasal AA (INAA), oral AA (POAA3 or POAA30), or donepezil, followed by scopolamine for 10 days. Morris water maze (MWM) was performed on days 0–5, 30 min after treatment. Locomotor activity was conducted on day 6 followed by brain collection. In MWM, INAA treatment had significantly reduced escape latency on days 2–4, while POAA3 decreased escape latency on day 3 and POAA30 and donepezil decreased escape latency on day 4. INAA inhibited acetylcholinesterase activity, increased catalase protein expression, and decreased malondialdehyde levels in the brain tissue. Therefore, intranasal administration of AA produced a rapid onset in the protection of learning and memory deficits induced by scopolamine through acetylcholinesterase inhibition and antioxidant effect.
- Open Access
- 25 July 2022
- Published by Pensoft Publishers in Pharmacia
- Vol. 69 (3) , 689-697
Construction of network pharmacology-based approach and potential mechanism from major components of Coriander sativum L. against COVID-19
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Despite the fact that various therapeutic compounds have shown potential prevention or treatment, no specific medicine has been developed for the COVID-19 pandemic. Natural products have recently been suggested as a possible treatment option for COVID-19 prevention and treatment. This study focused on the potential of Coriander sativum L. (CSL) against COVID-19 based on network pharmacology approach. Interested candidates of CSL were identified by searching accessible databases for protein–protein interactions with the COVID-19. An additional GO and KEGG pathway analysis was carried out in order to identify the related mechanism of action. In the end, 51 targets were obtained through network pharmacology analysis with EGFR, AR, JAK2, PARP1, and CTSB become the core target. CSL may have favorable effects on COVID-19 through a number of important pathways, according to GO and KEGG pathway analyses. These findings suggest that CSL may prevent and inhibit the several processes related to COVID-19.
- 25 July 2022
- Published by Pensoft Publishers in Pharmacia
- Vol. 69 (3) , 689-697
Open AccessConstruction of network pharmacology-based approach and potential mechanism from major components of Coriander sativum L. against COVID-19
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Despite the fact that various therapeutic compounds have shown potential prevention or treatment, no specific medicine has been developed for the COVID-19 pandemic. Natural products have recently been suggested as a possible treatment option for COVID-19 prevention and treatment. This study focused on the potential of Coriander sativum L. (CSL) against COVID-19 based on network pharmacology approach. Interested candidates of CSL were identified by searching accessible databases for protein–protein interactions with the COVID-19. An additional GO and KEGG pathway analysis was carried out in order to identify the related mechanism of action. In the end, 51 targets were obtained through network pharmacology analysis with EGFR, AR, JAK2, PARP1, and CTSB become the core target. CSL may have favorable effects on COVID-19 through a number of important pathways, according to GO and KEGG pathway analyses. These findings suggest that CSL may prevent and inhibit the several processes related to COVID-19.
- 3 July 2022
- Published by Rynnye Lyan Resources in Food Research
- Vol. 6 (4) , 399-406
Evaluation of stability and quality characteristics of moringa (Moringa oleifera) herbal tea during storage
Determining the product’s shelf life was necessary to ensure its quality, effectiveness, and safety. This study aimed to determine the stability of moringa tea products. The real-time stability test was carried out at room temperature (28.5‒33.5°C) with 50‒75% relative humidity, and the sampling interval was once every third month (Month-0, Month-3 and Month-6). Physical parameters (organoleptic properties and moisture content), chemical parameters (total phenolic content and total flavonoid content), and microbial parameters (total plate count and total yeast and mould count) were measured using the standard procedures. The organoleptic test showed no changes in colour, taste, smell, and shape of the teabag and brewed tea products up to the sixth month of evaluation. However, there were significant changes in the moisture content (MC), total phenolic content (TPhC), and total plate count (TPC) of the teabag and only in the TPhC of the brewed tea product throughout the quality control. Physical, chemical, and microbial parameters still met the quality requirements set by the Pharmacopoeia Herbal Indonesia and the Indonesian Food and Drug Authority. The qualities of moringa tea bags and brewed moringa teas stored at room temperature (28.5‒33.5°C) and 50‒75% relative humidity showed good physicochemical properties and stability in the test during six months of observation.
- 3 July 2022
- Published by Rynnye Lyan Resources in Food Research
- Vol. 6 (4) , 399-406
Evaluation of stability and quality characteristics of moringa (Moringa oleifera) herbal tea during storage
Determining the product’s shelf life was necessary to ensure its quality, effectiveness, and safety. This study aimed to determine the stability of moringa tea products. The real-time stability test was carried out at room temperature (28.5‒33.5°C) with 50‒75% relative humidity, and the sampling interval was once every third month (Month-0, Month-3 and Month-6). Physical parameters (organoleptic properties and moisture content), chemical parameters (total phenolic content and total flavonoid content), and microbial parameters (total plate count and total yeast and mould count) were measured using the standard procedures. The organoleptic test showed no changes in colour, taste, smell, and shape of the teabag and brewed tea products up to the sixth month of evaluation. However, there were significant changes in the moisture content (MC), total phenolic content (TPhC), and total plate count (TPC) of the teabag and only in the TPhC of the brewed tea product throughout the quality control. Physical, chemical, and microbial parameters still met the quality requirements set by the Pharmacopoeia Herbal Indonesia and the Indonesian Food and Drug Authority. The qualities of moringa tea bags and brewed moringa teas stored at room temperature (28.5‒33.5°C) and 50‒75% relative humidity showed good physicochemical properties and stability in the test during six months of observation.
- Open Access
- 10 September 2019
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 31-34
SUBCHRONIC ORAL TOXICITY TEST FOR 28 DAYS OF SAUROPUS ANDROGYNOUS L. MERR. LEAVES SOUP IN WISTAR FEMALE RATS
Objective: The objective of the study was to evaluate the subchronic toxicity of Sauropus androgynus L. Merr. leaves soup. Methods: Subchronic oral toxicity tests were carried out for 28 days in female Wistar rats using conventional methods. Thirty rats were divided into six groups, namely, one control group and three test groups with each extract being given at a dose of 500 mg/kg body weight (BW), 1000 mg/kg BW, and 3000 mg/kg BW, and one group satellite control and satellite test group with doses of 3000 mg/kg BW were carried out for 14 days after 28 days of treatment to see the effects of reversibility. All rat groups were observed for behavior, development of BW, serum glutamic pyruvic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), creatinine serum, ratio of liver and lung organs to BW, and histology of liver and lung. Results: The macroscopic observation of rat’s lung and rat weight ratio did not show a significant difference to the control group (p>0.05). In addition, the ratio of liver volume to BW was significantly different between the doses of 1000 mg/kg BW and 3000 mg/kg BW with satellite groups 3000 mg/kg BW (p0.05). However, creatinine serum had the highest increase at a dose of 500 mg/kg BW and a dose of 1000 mg/kg BW. Reversibility effects were not seen after 14 days of the past day given Sauropus androgynous soup for 28 days in female Wistar rats. Conclusion: The given of S. androgynous soup for 28 days for female Wistar rats did not show any specific toxicity effect so that its use was relatively safe for the consumption under 30 days. This study is expected to be the information source about the safety profile of S. androgynus leaves soup consumption.
- 10 September 2019
- Published by Innovare Academic Sciences Pvt Ltd in Asian Journal of Pharmaceutical and Clinical Research
- p. 31-34
Open AccessSUBCHRONIC ORAL TOXICITY TEST FOR 28 DAYS OF SAUROPUS ANDROGYNOUS L. MERR. LEAVES SOUP IN WISTAR FEMALE RATS
Objective: The objective of the study was to evaluate the subchronic toxicity of Sauropus androgynus L. Merr. leaves soup. Methods: Subchronic oral toxicity tests were carried out for 28 days in female Wistar rats using conventional methods. Thirty rats were divided into six groups, namely, one control group and three test groups with each extract being given at a dose of 500 mg/kg body weight (BW), 1000 mg/kg BW, and 3000 mg/kg BW, and one group satellite control and satellite test group with doses of 3000 mg/kg BW were carried out for 14 days after 28 days of treatment to see the effects of reversibility. All rat groups were observed for behavior, development of BW, serum glutamic pyruvic transaminase (SGPT), serum glutamic oxaloacetic transaminase (SGOT), creatinine serum, ratio of liver and lung organs to BW, and histology of liver and lung. Results: The macroscopic observation of rat’s lung and rat weight ratio did not show a significant difference to the control group (p>0.05). In addition, the ratio of liver volume to BW was significantly different between the doses of 1000 mg/kg BW and 3000 mg/kg BW with satellite groups 3000 mg/kg BW (p0.05). However, creatinine serum had the highest increase at a dose of 500 mg/kg BW and a dose of 1000 mg/kg BW. Reversibility effects were not seen after 14 days of the past day given Sauropus androgynous soup for 28 days in female Wistar rats. Conclusion: The given of S. androgynous soup for 28 days for female Wistar rats did not show any specific toxicity effect so that its use was relatively safe for the consumption under 30 days. This study is expected to be the information source about the safety profile of S. androgynus leaves soup consumption.